Malignant fungating wounds: managing malodour and exudate.
Contemporary wound management practices are not always applicable to the non-healing status of malignant wounds. Instead, care must be multidisciplinary, holistic and truly individual to the needs of each patient and their family.
Alexander
S
S
University, Bundaberg, Australia. s.alexander@cqu.edu.au
D000890:Anti-Infective Agents / Q000008:administration & dosage; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D001458:Bandages; D002606:Charcoal / Q000627:therapeutic use; D003646:Debridement; D005122:Exudates and Transudates; D006801:Humans; D007466:Iodophors / Q000627:therapeutic use; D008795:Metronidazole / Q000008:administration & dosage; D009812:Odorants; D012834:Silver / Q000008:administration & dosage; D014945:Wound Healing / Q000502:physiology; D014947:Wounds and Injuries / Q000150:complications / Q000628:therapy
D000890:Anti-Infective Agents; D000891:Anti-Infective Agents, Local; D007466:Iodophors; D008795:Metronidazole; D002606:Charcoal; D012834:Silver; C038634:cadexomer iodine